REG - IDOX PLC - Establishment of EBT and Total Voting Rights

IdoxAnnouncement

17/03/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250317:nRSQ8100Aa&default-theme=true

RNS Number : 8100A  IDOX PLC  17 March 2025

17 March 2025

Idox plc

('Idox' or the 'Group' or the 'Company')

Establishment of Employee Benefit Trust, Issue of Shares & Total Voting
Rights

 

Idox plc (AIM: IDOX) a leading supplier of specialist information management
software and geospatial data solutions to the public and asset-intensive
sectors, announces that it has established the Idox plc Employee Benefit Trust
(the "EBT").

 

Further to the establishment of the EBT, the Group issued 1,500,000 ordinary
shares in the Company of 1 pence each (the "Allotment Shares") to Ocorian
Trustees (Jersey) Limited (the "Trustee"), acting in its capacity as trustee
of the EBT. The EBT is an employees' share scheme within the meaning of
section 1166 of the Companies Act 2006; its purpose is to hold ordinary shares
for the benefit of the Company's employees so that the Trustee can, in
accordance with the terms of the EBT, use the Allotment Shares to satisfy the
exercise of options and awards for the beneficiaries of the EBT under the
Company's long term incentive plans ("LTIPs"). The EBT will be funded by the
Company by way of a loan. The Group may issue new ordinary shares to be
subscribed for by the EBT or the EBT may make market purchases of ordinary
shares to be held and used to satisfy the future vesting of share option
awards granted to participants under the rules of the LTIPs.

Following the above transaction, the EBT holds 1,500,000 ordinary shares,
representing approximately 0.33% of the Company's issued share capital.

An application will be made for admission to trading of the Allotment Shares
to AIM ("Admission"). Admission is expected to take place at 8.00 a.m. on or
around 20 March 2025. The Company holds no ordinary shares in treasury. The
total number of ordinary shares in issue following Admission will be
461,682,046. Therefore, the total number of ordinary shares with voting rights
in the Company will be 461,682,046.

The above figure of 461,682,046 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the Company under
the FCA's Disclosure and Transparency Rules.

 

 

For further information please contact:

 

 Idox plc                               +44 (0) 333 011 1200
 Chris Stone, Non-Executive Chairman    investorrelations@idoxgroup.com
 David Meaden, Chief Executive Officer
 Anoop Kang, Chief Financial Officer

 Peel Hunt LLP (NOMAD and Broker)       +44 (0) 20 7418 8900
 Benjamin Cryer
 Kate Bannatyne
 Adam Telling

 MHP                                    + 44 (0) 7855 447944
 Reg Hoare                               idox@mhpgroup.com (mailto:idox@mhpgroup.com)
 Ollie Hoare
 Matthew Taylor
 Finn Taylor

 

About Idox plc

For more information see www.idoxplc.com
(https://protect.checkpoint.com/v2/___http:/www.idoxplc.com/___.bXQtcHJvZC1jcC1ldXcyLTE6bmV4dDE1OmM6bzpmMmM2NGZiZmRiOGI3MTYzYmYzZGIwMjliZGQ4NjM2Nzo2OjEyMzI6NTY2MzdiNWFkMDE1YWY1MDA4ZGE3YzA0MTBlN2ZmNGEzZjBiYmQ2NTM0ZTIxMWMxMzgwNThhNDdlZTVhN2I2NzpwOkY6Tg)
@Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKQBKOBKDQND